Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/17/5/818/405530/mdl016.pdf
Reference42 articles.
1. Tamoxifen for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,1998
2. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1;Fisher;J Natl Cancer Inst,1998
3. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004;Winer;J Clin Oncol,2005
4. Steroid hormone receptors in breast cancer treatment strategy;McGuire;Recent Prog Hormone Res,1980
5. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J Clin Oncol,1999
Cited by 231 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. AL16ALA-SOD2 polymorphism predicts recurrence risk of breast cancer in patients treated with adjuvant tamoxifen;Advances in Cancer Biology - Metastasis;2023-10
2. Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer;European Journal of Cancer;2023-09
3. “Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”;Breast Cancer: Targets and Therapy;2023-07
4. A prospective cohort study of clinical characteristics and outcomes in Chinese patients with estrogen receptor-negative/progesterone receptor-positive early breast cancer;Breast Cancer Research and Treatment;2023-05-18
5. An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management;Journal of Personalized Medicine;2023-04-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3